Publication Cover
The Ultrasound Review of Obstetrics and Gynecology
the international journal of continuing education and current awareness
Volume 1, 2001 - Issue 1
4
Views
0
CrossRef citations to date
0
Altmetric
Original Article

Fetal gene therapy

, , , &
Pages 14-27 | Accepted 26 Jan 2001, Published online: 04 Dec 2011

References

  • Clothier CM. Report of the Committee on the Ethics of Gene Therapy. CM 1788. London: HMSO Publications, 1992
  • Blaese RM. T lymphocyte-directed gene therapy for ADA-SCID: initial trial results after 4 years. Science 1995;270:475–80
  • Cavazzana-Calvo M, Hacein-Bey S, de Saint Basile G, et al. Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease. Science 2000; 288:669–72
  • Kay MA, Manno CS, Ragni MV, et al. Evidence for gene transfer and expression of factor IX in haemophilia B patients treated with an AAV vector. Nature Genet 2000;24:257–61
  • Lehrman S. Virus treatment questioned after gene therapy death. Nature 1999;401:517–18
  • Coutelle C, Douar A-M, Colledge WH, et al. The challenge of fetal gene therapy. Nature Med 1995; 1:864–6
  • Gene Therapy Advisory Committee. Report on the potential use of gene therapy in utero. Hum Gene Ther 1999;10:689–92
  • Gaillard D, Ruocco S, Lallemand A, et al. Immuno- histochemical localization of cystic fibrosis transmembrane conductance regulator in human fetal airway and digestive mucosa. Pediatr Res 1994; 36:137–43
  • Tizzano EF, O’Brodovich H, Chitayat D, et al. Regional expression of CFTR in developing human respiratory tissues. Am J Respir Cell Mol Biol 1994; 10:355–62
  • Trezise AE. Expression of the cystic fibrosis gene in human foetal tissues. Hum Mol Genet 1993;2:212–18
  • Boue A. Prenatal diagnosis in 200 pregnancies with a 1-in-4 risk of cystic fibrosis. Hum Genet 1986;74:288–97
  • Harris A, Coleman L. Ductal epithelial cells cultured from human foetal epididymis and vas deferens: relevance to sterility in cystic fibrosis. J Cell Sci 1989;92:687–90
  • Coutelle C, Themis M, Schneider H, et al. Fetal somatic gene therapy – a preventive approach to the treatment of genetic disease: the case for. In Holzgreve H, Lessl M, eds. Stem Cells from Cord Blood, In Utero Stem Cell Development, and Transplantation- inclusive Gene Therapy. Berlin: Springer Verlag, 2000, 99–114
  • Goldman MJ, Wilson JM. Expression of alpha v beta 5 integrin is necessary for efficient adenovirus- mediated gene transfer in the human airway. J Virol 1995;69:5951–8
  • Goldman MJ, Wilson JM. Gradient of RGD dependent entry of adenoviral vector in nasal and intrapulmonary epithelia. Implications of cystic fibrosis. Gene Ther 1996;3:811–18
  • Furie B, Limentani SA, Rosenfield CG. A practical guide to the evaluation and treatment of hemo- philia. Blood 1994;84:3–9
  • Themis M. Enhanced in vitro and in vivo gene delivery using cationic agent complexed retrovirus vectors. Gene Ther 1998;5:1180–6
  • Douar A-M, Adebakin S, Themis M, et al. Foetal gene delivery in mice by intra-amniotic administration of retroviral producer cells and adenovirus. Gene Ther 1997;4:883–90
  • Russel DW, Berger MS, Miller AD. The effects of human serum and cerebrospinal fluid on retroviral vectors and packaging cell lines. Hum Gene Ther 1995;6:635–41
  • Palmer TD, Rosman GJ, Osborne WRA, et al. Genetically modified skin fibroblasts persist long after transplantation but gradually inactivate intro- duced genes. Proc Natl Acad Sci Am 1991;88:1330–4
  • Challita PM, Kohn DB. Lack of expression from a retroviral vector after transduction of murine hematopoietic stem cells is associated with methylation in vivo. Proc Natl Acad Sci Am 1994;91:2567–71
  • Ekhterae D, Crumbleholme T, Karson E, et al. Retroviral vector-mediated transfer of the bacterial neomycin resistance gene into fetal and adult sheep and human hematopoietic progenitors in vitro. Blood 1990;75:365–9
  • Douar A-M. Effect of amniotic fluid on cationic lipid mediated transfection and viral infection. Gene Ther 1996;3:789–96
  • Welsh RJ, Cooper NR, Jensen FC, et al. Human serum lyses RNA tumor viruses. Nature 1975;257:612–14
  • Cosset F-L. High-titer packaging cells producing recombinant retroviruses resistant to human serum. J Virol 1995;69:7430–6
  • Porada CD, Tran N, Eglitis M, et al. In utero</i> gene therapy: transfer and long-term expression of the bacterial neor gene in sheep after direct injection of retroviral vectors into preimmune fetuses. Hum Gene Ther 1998;9:1571–85
  • Pitt BR, Schwarz MA, Pilewski JM, et al. Retrovirus-mediated gene transfer in lungs of living fetal sheep. Gene Ther 1995;2:344–50
  • Hatzoglou M, Moorman A, Lamers W. Persistent expression of genes transferred in the fetal rat liver via retroviruses. Somat Cell Mol Genet 1995; 21:265–78
  • Trono D. Lentiviral vectors: turning a deadly foe into a therapeutic agent. Gene Ther 2000;7:20–3
  • Naldini L. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 1996;272:263–7
  • Case SS, Price MA, Jordan CT, et al. Stable transduction of quiescent CD34(+)CD38() human hematopoietic cells by HIV-1-based lentiviral vectors. Proc Natl Acad Sci Am 1999; 96:2988–93
  • Dull T. A third-generation lentivirus vector with a conditional packaging system. J Virol 1998;72:8463–71
  • Klages N, Zufferey R, Trono D. A stable system for the high-titer production of multiply attenuated lentiviral vectors. Mol Ther 2000;2:170–6
  • Miyoshi H, Verma IM, Takahashi M, et al. Develop- ment of a self-inactivating lentivirus vector. J Virol 1998;72:8150–7
  • Johnston J, Power C. Productive infection of human peripheral blood mononuclear cells by feline immunodeficiency virus: implications for vector development. J Virol 1999;73:2491–8
  • Wang L, Takabe K, Bidlingmaier SM, et al. Sustained correction of bleeding disorder in hemophilia B mice by gene therapy. Proc Natl Acad Sci Am 1999;96
  • Herzog RW, Yang EY, Couto LB, et al. Long-term correction of canine hemophilia B by gene transfer of blood coagulation factor IX mediated by adeno-associated viral vector. Nature Med 1999; 5:56–63
  • Schachtner SK, Buck CA, Bergelson JM, et al. Temporally regulated expression patterns following in utero adenovirus-mediated gene transfer. Gene Ther 1996;6:1249–57
  • Holzinger A, Trapnell BC, Weaver TE, et al. Intra- amniotic administration of an adenoviral vector for gene transfer to fetal sheep and mouse tissues. Pediatr Res 1995;38:844–50
  • Larson JE, Morrow SL, Happel L, et al. Reversal of cystic fibrosis phenotype in mice by gene therapy in utero. Lancet 1997;349:619–20
  • Themis M, Schneider H, Kiserud T, et al. Successful expression of β-galactosidase and factor IX transgenes in fetal and neonatal sheep after ultra- sound-guided percutaneous adenovirus vector administration into the umbilical vein. Gene Ther 1999;6:1239–48
  • McCray PB, Armstrong K, Zabner J, et al. Adenoviral-mediated gene transfer to fetal pulmonary epithelia in vitro and in vivo. <i>J Clin Invest 1995;95:2620–32
  • Schneider H, Adebakin S, Themis M, et al. Therapeutic plasma concentrations of human factor IX in mice after gene delivery into the amniotic cavity: a model for the prenatal treatment of haemophilia B. J Gene Med 1999;1:424–32
  • Iwamoto HS, Trapnell BC, McConnell CJ, et al. Pulmonary inflammation associated with repeated, prenatal exposure to an E1, E3-deleted adenoviral vector in sheep. Gene Ther 1999;6:98–106
  • Sylvester KG, Yang EY, Cass DL, et al. Fetoscopic gene therapy for congenital lung disease. J Pediatr Surg 1997;7:964–9
  • Sekhon HS, Larson JE. In utero gene transfer into the pulmonary epithelium. Nature Med 1995;1:1201–3
  • Woo YJ, Raju GP, Swain JL, et al. In utero cardiac gene transfer via intraplacental delivery of recombinant adenovirus. Circulation 1997;96:3561–9
  • Yang EY, Cass DL, Sylvester KG, et al. Fetal gene therapy: efficacy, toxicity, and immunologic effects of early gestation recombinant adenovirus. J Pediatr Surg 1999;34:235–41
  • Lipshutz GS, Flebbe-Rehwaldt L, Gaensler KML. Adenovirus-mediated gene transfer to the peritoneum and hepatic parenchyma of fetal mice in utero. Surgery 1999;126:171–7
  • Baldwin HS. Adenovirus-mediated gene transfer during initial organogenesis in the mammalian embryo is promoter-dependent and tissue-specific. Gene Ther 1997;4:1142–9
  • Wang G. Ultrasound-guided gene therapy to hepatocytes in utero. Fetal Diagn Ther 1998;13:197–205
  • Wu Y, Liu J, Woo S, et al. Prenatal orogastric gene delivery results in transduction of the small bowel in the fetal rabbit. Fetal Diagn Ther 1999;14:323–7
  • Senoo M, Matsubara Y, Fujii K, et al. Adenovirus-mediated in utero gene transfer in mice and guinea pigs: tissue distribution of recombinant adenovirus determined by quantitative TaqMan- polymerase chain reaction assay. Mol Gene Metab 2000;69:269–76
  • Petkov PM, Kim K, Sandhu J, et al. Identification of differentially expressed genes in epithelial stem/progenitor cells of fetal rat liver. Genomics 2000;68:197–209
  • Engelhardt JF, Ye X, Doranz B, et al. Ablation of E2A in recombinant adenoviruses improves transgene persistence and decreases inflammatory response in mouse liver. Proc Natl Acad Sci Am 1994;91:6196–200
  • Kass-Eisler A. Circumventing the immune response to adenovirus-mediated gene therapy. Gene Ther 1996;3:154–62
  • Chen P, Kovesdi I, Bruder JT. Effective repeat administration with adenovirus vectors to the mus- cle. Gene Ther 2000;7:587–95
  • Chen HH, Mack LM, Kelly R, et al. Persistence in muscle of an adenoviral vector that lacks all viral genes. Proc Natl Acad Sci Am1997;94:1645–50
  • Schiedner G, Morral N, Parks RJ, et al. Genomic DNA transfer with a high-capacity adenovirus vector results in improved in vivo gene expression and decreased toxicity. Nature Genet 1998;18:180–3
  • Murphy SJ, Bell SJ, Chong H, et al. Adenovirus- mediated delivery of an excisable retroviral cassette which can stable integrate into target cell genomes. J Gene Med 1998;1 Suppl:74
  • Feng M, Jackson WH, Goldman CK, et al. Stable in vivo gene transduction via a novel adenoviral/ retroviral chimeric vector. Nature Biotechnol 1997;15:866–70
  • Clapp DW, Dumenco LL, Hatzoglou M, et al. Fetal liver hematopoietic stem cells as a target for in utero retroviral gene transfer. Blood 1991;78:1132–9
  • Barbera A, Jones OW, Zerbe GW, et al. Ultrasonographic assessment of fetal growth: comparison between human and ovine fetus. Am J Obstet Gynecol 1995;173:1765–9
  • Aiumlamai S, Fredriksson G, Nilsfors L. Real-time ultrasonography for determining the gestational age of ewes. Veterinary Rec 1992;131:560–2
  • Sergeev L, Kleeman DO, Walker SK. Real-time ultrasound imaging for predicting ovine fetal age. Theriogenology 1990;34:593–601
  • Logue DN, Hall JT, McRoberts S, et al. Realtime ultrasound scanning in sheep: the results of the first year of its application on farms in southwest Scotland. Veterinary Rec 1987;121:146–9
  • Newnham JP, Kelly RW, Neilson JP, et al., eds. Ultrasound for research with fetal sheep. In Obstetric Ultrasound, 1st edn. Oxford: Oxford Medical Publications, 1993:203–22
  • Barbera A, Jones OW, Zerbe GW, et al. Early ultrasonographic detection of fetal growth retardation in an ovine model of placental insufficiency. Am J Obstet Gynecol 1995;173:1071–4
  • Galan HL, Hussey MJ, Barbera A, et al. Relationship of fetal growth to duration of heat stress in an ovine model of placental insufficiency. Am J Obstet Gynecol 1999;180:1278–82
  • Newnham JP, Polk DH, Kelly RW, et al. Cate- cholamine response to ultrasonographically guided percutaneous blood sampling in fetal sheep. Am J Obstet Gynecol 1994;171:465
  • Mason CA. Gene transfer in utero biologically engineers a patent ductus arteriosus in lambs by arresting fibronectin-dependent neointimal formation. Nature Med 1999;5:176–82
  • Westlake VJ, Jolly RD, Boyd RJ. Hematopoietic cell transplantation in fetal lambs with ceroid- lipofuscinosis. Am J Med Genet 1995;57:365–8
  • Tebbutt SJ, Harris A, Hill DF. An ovine CFTR variant as a putative cystic fibrosis causing mutation. J Med Genet 1996;33:623–4
  • Harris A. Towards an ovine model of cystic fibrosis. Hum Mol Genet 1997;6:2191–4
  • Türkay A, Saunders TL, Kurachi K. Intrauterine gene transfer: gestational stage-specific gene delivery in mice. Gene Ther 1999;6:1685–94
  • Xing A, Boileau P, Caüzac M, et al. Comparative in vivo approaches for selective adenovirus-mediated gene delivery to the placenta. Hum Gene Ther 2000;11:167–77
  • Hiltunen MO, Heikkilä A, Turunen MP, et al. Gene transfer to placenta. FIGO 2000
  • Papaioannou VE, Copp AJ, Cockroft DL, eds. In utero manipulations. In Postimplantation Mammalian Embryos. A Practical Approach. Oxford: JRL Press, 1990:61–80
  • Larson JE, Morrow SL, Delcarpio JB, et al. Gene transfer into the fetal primate: evidence for the secretion of transgene product. Mol Ther 2000;2:631–9
  • Khavari PA. Gene therapy for genetic skin disease. J Invest Dermatol 1998;110:462–7
  • Schittny JC, Miserocchi G, Sparrow MP. Spontaneous peristaltic airway contractions propel lung liquid through the bronchial tree of intact and fetal lung explants. Am J Respir Cell Mol Biol 2000;23:11–18
  • Kalache KD, Chaoui R, Marcks B, et al. Differ- entiation between human fetal breathing patterns by investigation of breathing-related tracheal fluid flow velocity using Doppler sonography. Prenat Diagn 2000;20:45–50
  • Badalian SS, Chao CR, Fox HE, et al. Fetal breathing-related nasal fluid flow velocity in uncomplicated pregnancies. Am J Obstet Gynecol 1993;169:563–7
  • Vincent MC, Trapnell BC, Baughman RP, et al. Adenovirus-mediated gene transfer to the respiratory tract of fetal sheep in utero. Hum Gene Ther 1995;6:1019–28
  • Nabel EG. Delivering genes to the heart – right where it counts! Nature Med 1999;5:141–2
  • Christensen G, Minamisawa S, Gruber PJ, et al. High-efficiency, long-term cardiac expression of foreign genes in living mouse embryos and neonates. Circulation 2000;101:178–84
  • Moise KJ, Hesketh DE, Belfort MM, et al. Ultrasound-guided blood sampling of rabbit fetuses. Lab Amin Sci 1992;42:398–401
  • Jensen A, Berger R. Fetal circulatory responses to oxygen lack. J Dev Physiol 1991;16:181–207
  • Yang EY, Kim HB, Shaaban AF, et al. Persistent postnatal transgene expression in both muscle and liver after fetal injection of recombinant adenovirus. J Pediatr Surg 1999;34:766–72
  • Tran ND, Porada CD, Zhao Y, et al. In utero and transfer and expression of exogenous genes in sheep. Exp Hematol 2000;28:17–30
  • Lipshutz GS, Flebbe-Rehwaldt L, Gaensler KML. Adenovirus-mediated gene transfer in the mid- gestation fetal mouse. J Surg Res 1999;84:150–6
  • Lipshutz GS, Flebbe-Rehwaldt L, Gaensler KML. Reexpression following readministration of an adenoviral vector in adult mice after initial in utero adenoviral administration. Mol Ther 2000;2:374–80
  • Brandt ML, Moise KJJ, Eckert JW, et al. Trans- uterine puncture of the fetal stomach provides access to the small bowel in the rabbit. J Invest Surg 1997;10:41–6
  • Keleman E, Calvo W, Eliedner TM. Atlas of Human Hemopoietic Development. Berlin: Springer-Verlag, 1979
  • Pahal GS, Jauniaux E, Kinnon C, et al. Normal development of human fetal hematopoiesis between eight and seventeen weeks’ gestation. Am J Obstet Gynecol 2000;183:1029–34
  • Mackenzie IZ, Maclean DA. Pure fetal blood from the umbilical cord obtained at fetoscopy: experience with 125 consecutive cases. Am J Obstet Gynecol 1980;138:1214–18
  • Phillips JH, Hori T, Nagler A, et al. Ontogeny of human natural killer (NK) cells: fetal NK cells mediate cytolytic function and express cytoplasmic CD3 epsilon, delta proteins. J Exp Med 1992;175:1055–66
  • Miyagawa Y, Matsuoka T, Baba A, et al. Fetal liver T cell receptor gamma/delta+ T cells as cytotoxic T lymphocytes specific for maternal alloantigens. J Exp Med 1992;176:1–7
  • Morris B. The ontogeny and comportment of lymphoid cells in fetal and neonatal sheep. Immunol Rev 1986;91:219–33
  • Silverstein AM, Uhr JW, Lukes RJ. Fetal response to antigenic stimulus. II. Antibody production by the fetal lamb. J Exp Med 1963;117:799–812
  • Silverstein AM, Prendergast RA, Kraner KL. Fetal response to antigenic stimulus. IV. Rejection of skin homografts by the fetal lamb. J Exp Med 1964; 119:955–64
  • Jauniaux E, Gulbis B. Fluid compartments of the embryonic environment. Hum Reprod Update 2000;6:268–78
  • Ross J, Jurkovic D, Nicolaides KH. Coelocentesis: a study of short-term safety. Prenat Diagn 1997; 17:913–17
  • Chinnaiya A, Venkat A, Dawn C, et al. Intra- hepatic vein fetal blood sampling: current role in prenatal diagnosis. J Obstet Gynaecol Res 1998;24:239–46
  • Nicolini U, Nicolaidis P, Fisk NM, et al. Fetal blood sampling from the intrahepatic vein: analysis of safety and clinical experience with 214 procedures. Obstet Gynecol 1990;76:47–53
  • Nicolaidis P, Nicolini U, Fisk NM, et al. Fetal blood sampling from the intrahepatic vein for rapid karyo- typing in the second and third trimesters. Br J Radiol 1991;64:505–9
  • Jauniaux E, Gulbis B, Gerloo E. Free amino acids in human fetal liver and fluids at 12–17 weeks of gestation. Hum Reprod 1999;14:1638–41
  • Jauniaux E, Gulbis B, Acharya G, et al. Fetal amino acid and enzyme levels with maternal smoking. Obstet Gynecol 1999;93:680–3
  • Westgren M. Tissue distribution of transplanted fetal liver cells in the human fetal recipient. Am J Obstet Gynecol 1997;176:49–53
  • Bambach BJ, Moser HW, Blackmore K. Engraftment following in utero bone marrow transplantation for globoid cell leukodystrophy. Bone Marrow Transplant 1997;19:399–402
  • Flake AW, Roncarolo MG, Puck JM. Treatment of X-linked severe combined immunodeficiency by in utero transplantation of paternal bone marrow. N Engl J Med 1996;335:1806–10
  • Touraine JL. Induction of transplantation tolerance in humans using stem cell transplants prenatally or postnatally. Transplant Proc 1999;31:2735–7
  • Ville Y, Khalil A, Homphray T, et al. Diagnostic embryoscopy and fetoscopy in the first trimester of pregnancy. Prenat Diagn 1997;17:1237–46
  • Fox JL. Future tense for in utero gene therapy. Nature Biotechnol 1998;16:1002–3
  • Moulton G. Panel finds in utero gene therapy proposal is premature. J Natl Cancer Inst 1999;91:407–8
  • Kazazian H. An estimated frequency of endogenous insertional mutations in humans. Nature Genet 1999;22:130

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.